Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting

doi:10.3748/wjg.v23.i22.4072

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7986)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

597

WORD

304

HTML

3667

Figures (1-2)

219

Tables (1-3)

194

Sum=4981

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1038

Download

1967

Sum=3005

Jun 14, 2017 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jun 14, 2017; 23(22): 4072-4079
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4072

Full Size Figure Download Figure

Figure 1 Diagram of detailed treatment regimens for 54 chronic hepatitis C patients and the treatment efficacy. CHC: Chronic hepatitis C; RVR 2: Rapid virological response at 2 wk after treatment initiation; SVR 24: Sustained virological response at 24 wk after the end of treatment.

Citation: Chen JH, Zeng Z, Zhang XX, Zhang Y, Zhang RW, Wang S, Wu CH, Yu M, Liu D, Xi HL, Zhou YX, An YY, Xu XY. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting. World J Gastroenterol 2017; 23(22): 4072-4079
URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4072.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i22.4072